AB
Andrew Booth bought $97K of ABCL stock
Andrew Booth, Chief Financial Officer of AbCellera Biologics Inc. (ABCL), bought 8,600 shares of ABCL stock worth $97K, per an SEC Form 4 filed Nov 13, 2026.
It was an open-market purchase.
The trade was reported on Nov 13, 2026.
- Traded
- Nov 13, 2026
- Disclosed
- Nov 13, 2026
- Filing delay
- 0 days
- Role
- Chief Financial Officer
- Source
- SEC Form 4